I know IMCL and others are working on bispecific antibodies. Does anyone know of any companies/groups that are working on covalently linking two therapeutic monoclonal antibodies so that two distinct antibodies can be linked. put in one bottle, and treated as one drug from a regulatory perspective. Comments appreciated.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.